Moderna Inc (NASDAQ:MRNA)
| 98.63 Delayed Data As of Nov 24 |  -2.40 / -2.38%Today’s Change | 17.68 Today|||52-Week Range 103.20 | +404.24% Year-to-Date |
Latest MRNA News | Press Releases
| ETFs to Play as Vaccine News Looks to Outdo Virus Fear Nov 24 / Zacks.com - Paid Partner Content | Sanofi's (SNY) Meningitis Vaccine MenQuadfi Wins EU Approval Nov 24 / Zacks.com - Paid Partner Content |
| Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU Nov 24 / MotleyFool.com - Paid Partner Content | 3 Coronavirus Vaccine Makers Near Finish Line in November Nov 24 / Zacks.com - Paid Partner Content |
| Spread of Top-Ranked Value ETFs to Bet on Vaccine Optimism Nov 24 / Zacks.com - Paid Partner Content | Celebrate Thanksgiving Week With These ETFs Nov 24 / Zacks.com - Paid Partner Content |
| How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'? Nov 24 / Zacks.com - Paid Partner Content | 5 Top-Performing Leveraged ETF Areas of Last Week Nov 24 / Zacks.com - Paid Partner Content |
| 5 ETFs That Gained in Double Digits Last Week Nov 24 / Zacks.com - Paid Partner Content | Coronavirus Vaccine Stocks: Is There Room For Multiple Winners? Nov 24 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 101.03 |
| Today’s open | 98.25 |
| Day’s range | 93.57 - 99.87 |
| Volume | 348,053 |
| Average volume (3 months) | 13,670,799 |
| Market cap | $38.6B |
Data as of 5:30pm ET, 11/24/2020
Growth & Valuation
| Earnings growth (last year) | +68.63% |
| Earnings growth (this year) | -17.60% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | -55.42% |
| P/E ratio | NM |
| Price/Sales | 107.47 |
| Price/Book | 27.96 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIIBBiogen | -0.74 | -0.30% |
| ILMNIllumina Inc | +3.81 | +1.26% |
| ---- | ||
| EXASExact Sciences Corp | -3.28 | -2.72% |
Data as of 4:36pm ET, 11/24/2020
Financials
| Next reporting date | March 10, 2021 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $60.2M |
| Annual profit (last year) | -$514.0M |
| Net profit margin | -853.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
